Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Mar;7(3):163-72.
doi: 10.1038/nrclinonc.2009.236. Epub 2010 Jan 26.

Advanced pancreatic carcinoma: current treatment and future challenges

Anastasios Stathis  1 , Malcolm J Moore
Affiliations
Review

Advanced pancreatic carcinoma: current treatment and future challenges

Anastasios Stathis et al. Nat Rev Clin Oncol. 2010 Mar.

Abstract

Pancreatic adenocarcinoma is the most lethal of the solid tumors and the fourth leading cause of cancer-related death in North America. Most patients present with locally advanced or metastatic disease that precludes curative resection. These patients have an extremely poor prognosis. In the absence of effective screening methods, considerable efforts have been made during the past decade to identify better systemic treatments. Unfortunately most trials have not shown a survival advantage for most therapies. In tandem with this increased clinical research, there has also been an expansion of preclinical laboratory investigation. These preclinical studies revealed many of the molecular mechanisms involved in pancreatic cancer development, which has provided insights into why current therapies are ineffective. These new discoveries provide some optimism that new agents inhibiting specific targets will improve outcome and overcome the resistance of pancreatic cancer to most standard treatments. We review the current standards of care for patients with locally advanced and metastatic pancreatic carcinoma and outline some future directions for the development of new treatment strategies.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Clin Oncol. 2004 Sep 15;22(18):3776-83 - PubMed
    1. N Engl J Med. 2004 Jun 24;350(26):2713-5; author reply 2713-5 - PubMed
    1. Ann Surg. 1995 Jun;221(6):721-31; discussion 731-3 - PubMed
    1. Ann Surg. 1999 Dec;230(6):776-82; discussion 782-4 - PubMed
    1. Br J Cancer. 2002 Jul 15;87(2):161-7 - PubMed

MeSH terms